Clinical Trial Update: Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating fisetin to improve physical function in stage I–III breast cancer survivors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fisetin (fisetin)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Status: RECRUITING